Allopurinol, a drug normally prescribed for gout, is being used to test for
tumours in patients at high risk of developing cancer due to genetic or
environmental factors. Developed by researchers at Johns Hopkins University in
Baltimore, Maryland, the test uses allopurinol to temporarily slow DNA
production in cancer cells, causing some components of DNA鈥攃alled
pyrimidines鈥攖o accumulate in the blood. These can be detected in the
patient’s urine.
More from New Scientist
Explore the latest news, articles and features
Popular articles
Trending New Scientist articles
1
Woman with Alzheimer's starts conversing again after taking psilocybin
2
If you aren't terrified by this heatwave, you should be
3
Where, when and how to watch the 2026 solar eclipse
4
How menopause radically changes the brain 鈥 and what happens after
5
Faecal transplant makes the brains of old mice act young again
6
We鈥檝e uncovered a master gene that switches on human development
7
Our verdict on The Selfish Gene: An unpopular piece of popular science
8
Europe鈥檚 heatwave is the hottest and most humid ever
9
The race to understand how and when Thwaites glacier will collapse
10
Lost books by ancient philosophers recovered from 'unreadable' scrolls
